BP
BIIB icon

BNP Paribas’s Biogen BIIB Stock Holding History

BNP Paribas’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$128K Hold
700
– – ﹤0.01% 240
2025
Q4 		$123K Sell
700
-104
-13% -$17K ﹤0.01% 256
2025
Q3 		$113K Hold
804
– – ﹤0.01% 237
2025
Q2 		$101K Sell
804
-70
-8% -$8.72K ﹤0.01% 248
2025
Q1 		$120K Buy
874
+70
+9% +$10K 0.01% 243
2024
Q4 		$123K Buy
804
+104
+15% +$17.5K ﹤0.01% 261
2024
Q3 		$136K Hold
700
– – 0.01% 244
2024
Q2 		$162K Hold
700
– – 0.01% 228
2024
Q1 		$151K Buy
+700
New +$164K 0.01% 240

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas's BIIB Position: Q1 2026 in Review

BNP Paribas held its Biogen (BIIB) position steady in Q1 2026 at 700 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #240.

BNP Paribas first reported a position in BIIB in Q1 2024 and has held it in 9 quarters since. The position peaked at $162K in Q2 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • BNP Paribas held 700 shares of Biogen worth $128K as of Q1 2026.
  • BNP Paribas left its Biogen share count unchanged in Q1 2026.
  • Biogen made up ﹤0.01% of BNP Paribas's portfolio in Q1 2026, its #240 holding.
  • BNP Paribas first reported a position in Biogen in Q1 2024 and has held it in 9 quarters since.
  • BNP Paribas's Biogen position peaked at $162K in Q2 2024.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.